AstraZeneca prices USD2 billion multi-year bond issuance
(Alliance News) - AstraZeneca PLC on Thursday priced a global bond offering worth USD2 billion. Read More
| Price | 15,542.00p on 27-02-2026 at 19:40:05 |
|---|---|
| Change | 432.00p 2.86% |
| Buy | 15,504.00p |
| Sell | 15,498.00p |
| Last Trade: | Unknown 0.00 at 15,544.83728p |
| Day's Volume: | 2,574,843 |
| Last Close: | 15,542.00p |
| Open: | 15,196.00p |
| ISIN: | GB0009895292 |
| Day's Range | 15,172.00p - 15,542.00p |
| 52wk Range: | 9,574.00p - 15,730.00p |
| Market Capitalisation: | £241.02b |
| VWAP: | 15,485.12801p |
| Shares in Issue: | 1.55b |
Astrazeneca (AZN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 0 | 15,544.83728p | Currency Conversion OTC Trade |
19:12:10 - 27-Feb-26 |
| Unknown* | 0 | 15,538.16886p | SI Trade Currency Conversion |
19:10:42 - 27-Feb-26 |
| Unknown* | 0 | 15,559.656p | SI Trade Currency Conversion |
19:09:28 - 27-Feb-26 |
| Unknown* | 0 | 15,559.656p | SI Trade Currency Conversion |
19:09:28 - 27-Feb-26 |
| Unknown* | 0 | 15,543.35541p | SI Trade Currency Conversion |
19:08:08 - 27-Feb-26 |
| Unknown* | 0 | 15,551.5057p | SI Trade Currency Conversion |
18:50:45 - 27-Feb-26 |
| Unknown* | 0 | 15,537.42792p | SI Trade Currency Conversion |
18:46:39 - 27-Feb-26 |
| Unknown* | 38 | 15,524.42449p | Cross Currency Conversion OTC Trade |
18:33:34 - 27-Feb-26 |
| Unknown* | 0 | 15,547.06009p | SI Trade Currency Conversion |
18:31:22 - 27-Feb-26 |
| Unknown* | 0 | 15,534.46418p | Currency Conversion OTC Trade |
18:29:30 - 27-Feb-26 |
Astrazeneca (AZN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 26th Feb 2026 7:00 am | RNS | AstraZeneca prices a $2bn bond offering |
| 25th Feb 2026 7:00 am | RNS | Filing of Form 20-F with SEC |
| 24th Feb 2026 11:00 am | RNS | Annual Financial Report |
| 24th Feb 2026 7:00 am | RNS | Directorate change |
| 20th Feb 2026 7:00 am | RNS | Fixed-duration Calquence combo approved in US |
| 10th Feb 2026 7:00 am | RNS | Final Results |
| 3rd Feb 2026 7:00 am | RNS | Update on Saphnelo subcutaneous administration |
| 2nd Feb 2026 3:00 pm | RNS | Total Voting Rights |
| 2nd Feb 2026 7:05 am | RNS | Imfinzi recommended in EU for early gastric cancer |
| 2nd Feb 2026 7:00 am | RNS | AstraZeneca begins trading on NYSE |